ArticleThe World Allergy Organization journal2026

Response to the comment regarding our article entitled "A 300 IR 5-grass pollen sublingual immunotherapy tablet-specific systematic review and meta-analysis confirms its clinical benefits for patients with allergic rhinoconjunctivitis with or without asthma".

Danilo Di Bona et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.